Clinical Trial Update: To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of 18F-FCH versus 18F-FDG for detecting hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 18F-FCH (fluoromethylcholine)
• 18F-FDG (fluorodeoxyglucose F-18)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatocellular Carcinoma, Liver Disease | Phase 3 | Status: UNKNOWN